Epidemiologic and genetic studies suggest a potentially causal association between elevated Lp(a) levels, atherosclerotic cardiovascular disease, and aortic valve stenosis. Emerging nucleic acid-based therapies have potent Lp(a)-lowering effects and appear safe; phase 3 trials will establish whether they improve cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: